America December 10, 2025
Apple Tree Filed for Chapter 11 Amid $97M Funding Dispute
Biotechnology investor Apple Tree Life Sciences Inc. and affiliated entities filed for Chapter 11 bankruptcy protection in Delaware on Tuesday,…
America December 10, 2025
Biotechnology investor Apple Tree Life Sciences Inc. and affiliated entities filed for Chapter 11 bankruptcy protection in Delaware on Tuesday,…
By Rihem Akkouche
America October 27, 2025
In a bold step that cements its place at the forefront of genetic medicine, Novartis AG announced Sunday that it…
By Rihem Akkouche
America October 24, 2025
Pharmaceutical powerhouse Eli Lilly and Co. announced Friday that it will acquire Adverum Biotechnologies, a clinical-stage gene therapy innovator targeting…
By Rihem Akkouche
America October 22, 2025
In a sweeping expansion of its cancer drug portfolio, global biopharmaceutical powerhouse Ipsen SAS announced Wednesday that it will acquire…
By Rihem Akkouche
America October 2, 2025
Singapore-based Nanyang Biologics Pte. Ltd. revealed Thursday it will go public in the U.S. via a merger with special purpose…
By Rihem Akkouche
America September 24, 2025
A high-profile courtroom showdown over DNA sequencing patents has ended abruptly. Labcorp and Natera reached a midtrial settlement in a…
By Rihem Akkouche
America February 24, 2025
Anne Wojcicki, CEO of 23andMe, has partnered with private equity powerhouse New Mountain Capital to take the pioneering genetic testing…
By Rihem Akkouche
America February 10, 2025
Biotechnology company Omega Therapeutics hit Chapter 11 bankruptcy in Delaware on Monday, listing more than $140 million in debt on…
By Rihem Akkouche
America June 14, 2024
Australian biotechnology firm Telix Pharmaceuticals Ltd., whose U.S. shares were set to debut trading on Friday, canceled plans for an…
By Rihem Akkouche
America April 17, 2024
In a dramatic shift in corporate strategy, Elliott Investment Management LP has relinquished an earlier pact with BioMarin Pharmaceutical Inc.,…
By Rihem Akkouche